Bamco Inc Biohaven Pharmaceutical Holding CO Ltd. Transaction History

Bamco Inc

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 13, 2022	SELL	$110.08 - $142.92 $21.8 Million - $28.3 Million	-197,980 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$99.73 - $148.48 $8.52 Million - $12.7 Million	85,463 Added 75.96%	197,980 $27.3 Million
Q3 2021 Nov 12, 2021	SELL	$98.85 - $138.91 $3.31 Million - $4.65 Million	-33,483 Reduced 22.93%	112,517 $15.6 Million
Q1 2021 May 19, 2021	SELL	$64.07 - $91.75 $812,087 - $1.16 Million	-12,675 Reduced 7.99%	146,000 $9.98 Million
Q4 2020 Feb 12, 2021	BUY	$65.07 - $98.24 $286,307 - $432,256	4,400 Added 2.85%	158,675 $13.6 Million

Q3 2020 Nov 13, 2020	BUY	$59.04 - $77.95 $171,216 - $226,055	2,900 Added 1.92%	154,275 $10 Million
Q1 2020 May 15, 2020	BUY	$27.51 - $57.29 $4.05 Million - $8.43 Million	147,075 Added 3420.35%	151,375 $5.15 Million
Q4 2019 Feb 18, 2020	BUY	$40.86 - $57.65 $175,698 - $247,895	4,300 New	4,300 $234,000

565K

Ticker BHVN
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 71,645,000
Market Cap $2.49B
Description
Biohaven Pharmaceutical Holding Company Ltd., a biopharmaceutical company, develops products candidates targeting neurological and neuropsychiatric diseases, and rare disorders in the United States. It offers NURTEC ODT (rimegepant) for the acute treatment of migraine, as well as developing Rimegepant for preventive treatment of migraine; Zavege...

Get notified when there are updates to the investment portfolio of Bamco Inc , based on Form 13F filings with the SEC.

Stay updated on Bamco Inc with notifications on news.